Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Microbot Medical Inc logo
MBOT

Microbot Medical Inc

MaveScore 18 Low model confidence
Last Price US$1.90 As of Jul 10, 2026
Market Cap US$128.3m Company size context
7D Performance -0.79% Past 7 days
1Y Performance -28.22% Past 12 months
Model Rating
Historical model output for research review

Fundamental data date

Mar 31, 2026

102 days old

Market price date

Jul 10, 2026

1 day old

Coverage

16/16

No missing model inputs

Data quality

Excellent

Current stored snapshot

Transparent research score

Why the model scores this stock

MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

MaveScore 18 Low confidence

Stored data quality

Freshness and coverage checks

16/16 Current stored snapshot

Quality

11/35 Weak

Blends latest model rank with profitability and dilution ranks.

Financial Strength

0/25 Weak

Rewards durable profitability, margins, and positive free cash flow.

Valuation Support

4/15 Weak

Favors positive earnings, positive cash flow, and lower multiples.

Momentum

2/15 Weak

Highlights research candidates with supportive 3-month and 6-month price regimes.

Shareholder Alignment

1/10 Weak

Rewards less dilutive share behavior and enough size for liquid research coverage.

Positive model output

More live company inputs are needed before positive research signals can be surfaced.

Research risks to review

  • Blends latest model rank with profitability and dilution ranks.
  • Rewards durable profitability, margins, and positive free cash flow.
  • Favors positive earnings, positive cash flow, and lower multiples.

MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting.

Dashboard Funda..tals Prediction Screener Map

Microbot Medical Inc Overview

Industry: Medical Instruments & Supplies

Sector: Healthcare

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Read More

Microbot Medical Inc is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.

Microbot Medical Inc

Score

Reported Results

What the company reported, with filing details kept small.

Filed May 13, 2026

Quarterly result summary

Latest company-filed earnings material is available for source review.

What changed

  • Review the SEC source filing for the full reported results and management commentary.

Guidance / outlook

No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

SEC filing Open filing

Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

Other recent earnings materials

Recent News



Earnings Per Share

Score 3.00/5
Microbot Medical Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
In Medical Instruments & Supplies industry , West Pharmaceutical Services Inc , Hologic Inc , Haemonetics are companies with high ratings.

Return on Equity

Score -0.38/5
Microbot Medical Inc exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
Microbot Med... MBOT US$128.3m
Zoetis Inc ZTS US$31.4b
IQVIA Holdin... IQV US$34.6b
Agilent Tech... A US$36.9b

Net Margin

Score 2.21/5
Microbot Medical Inc olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
Microbot Med... MBOT US$128.3m
Zoetis Inc ZTS US$31.4b
IQVIA Holdin... IQV US$34.6b
Agilent Tech... A US$36.9b

Share Buyback

In Medical Instruments & Supplies industry , West Pharmaceutical Services Inc , Hologic Inc , Haemonetics are companies with high ratings.

Leverage

Score 3.28/5
Microbot Medical Inc attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
Microbot Med... MBOT US$128.3m
Zoetis Inc ZTS US$31.4b
IQVIA Holdin... IQV US$34.6b
Agilent Tech... A US$36.9b

Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

SEC financial statements are temporarily unavailable.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Financial Ratio

Yearly Quarterly

Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios

Microbot Medical Inc logo

Microbot Medical Inc

US$1.90

US$128.3m

-0.79%

-28.22%